Pharmacokinetic Profile in Plasma & Epithelial Lining Fluid of

Clinical Trial Summary

This study investigates the safety, tolerability, and PK profile of finafloxacin as a novel fluoroquinolone and a potential therapeutic agent for lower respiratory infections such as bacterial pneumonia. A comparison of the PK profile of finafloxacin in plasma and lung ELF using different bronchoscopic ELF sampling techniques (BMS and BAL) is conducted.

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06000891` - A Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570	Phase 1
Active, not recruiting	`NCT05997641` - Evaluating the Safety, Tolerability, and Pharmacokinetics of DF-003 in Healthy Subjects	Phase 1
Completed	`NCT06181760` - A Study to Evaluate the Safety of Fenretinide in Healthy Volunteers	Phase 1
Recruiting	`NCT05907382` - Safety, Tolerability of JMKX003002 in Phase 1 Study in Healthy Subjects	Phase 1
Completed	`NCT01952548` - Study Comparing the Pharmacokinetics, Pharmacodynamics, and Safety of K-312 in Healthy Adult Volunteers	Phase 1
Recruiting	`NCT06453824` - SAD Evaluation of Safety, Tolerability, PK, and PD of MDI-2517 in Healthy Participants	Phase 1
Completed	`NCT05431634` - Multiple Dose Study to Determine Safety and Tolerability of ESK-001 in Healthy Participants	Phase 1
Recruiting	`NCT06331884` - Phase 1 Study to Evaluate Safety, Tolerability and Pharmacokinetics/-Dynamics of AK1967 (Procizumab)	Phase 1
Completed	`NCT03046589` - DP13 SAD & MAD in Healthy Male Subjects	Phase 1
Recruiting	`NCT06079541` - Phase 1 Clinical Study of JMKX003142 Tablets	Phase 1
Completed	`NCT05223660` - A Phase I Pharmacokinetics Study for KT07 Capsule	Phase 1
Completed	`NCT03809052` - A First in Human Study to Evaluate the Safety, Tolerability and PK of GB1211 in Healthy Subjects	Phase 1
Completed	`NCT03853421` - Placebo-controlled Study to Determine the Safety and Tolerability of Subcutaneous Doses of Sevuparin	Phase 1
Terminated	`NCT03307512` - PK and PD Profile of Dance 501 in Healthy, Non-diabetic Subjects With Mild to Moderate Asthma or COPD	Phase 2
Completed	`NCT03685708` - HEPLISAV-B Hepatitis B Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's-Tyrosine Kinase Inhibitor (BTK-I)	Phase 2
Completed	`NCT03702231` - Response to the SHINGRIX Varicella Zoster Virus (VZV) Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's Tyrosine Kinase Inhibitor (BTK-I)	Phase 2
Completed	`NCT03817346` - Study of Ascending Single Oral Dose of GT-002 in Healthy Volunteers	Phase 1
Active, not recruiting	`NCT01226316` - Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules	Phase 1
Completed	`NCT05451667` - Single-Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of YJ001 in Healthy Volunteers	Phase 1
Completed	`NCT02029482` - Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT-128800 in Healthy Subjects	Phase 1

NCT number	NCT01907867
Study type	Interventional
Source	MerLion Pharmaceuticals GmbH
Contact
Status	Completed
Phase	Phase 1
Start date	January 2012
Completion date	February 2012

Pharmacokinetic Profile in Plasma and Epithelial Lining Fluid of Finafloxacin

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms